Key

Clinical Squared and PlatoHealth Join Forces to Revolutionize Healthcare with Advanced Data Orchestration Powered by AI.

Washington DC, September 20th, 2023 — Clinical Squared (C2) and Platohealth.ai are delighted to announce a groundbreaking partnership that promises to reshape the healthcare landscape. Their collaboration brings together the healthcare expertise of C2 and the cutting-edge AI and machine learning capabilities of Plato.ai to create innovative solutions. [gallery columns="2" link="none" size="large" ids="2890769,2890768"] Clinical Squared, a leader in healthcare market expertise, data architecture, software development, consultation and implementation services, will lend its extensive industry knowledge to Plato.ai's platform. In turn, Plato.ai will provide advanced AI and machine learning mechanisms to

Ennova Holdings Launches Upgrade ‘TIER’ to Empower Africa’s Financial Future Through Blockchain Innovation

Revolutionary Blockchain Initiative Seeks to Eradicate Financial Inequality in Africa Highlights: Financial Freedom Vision: Ennova Holdings 'TIER’ introduces blockchain solutions to empower Africa's unbanked population. Educational Empowerment: The organization prioritizes blockchain education for African and Asian youth, fostering economic growth. Innovative Payment Solutions: A multi-tiered app offers accessible, rewarding financial transactions, surpassing traditional remittance services. Global Inclusion: Future plans include a global credit rating agency for the unbanked, bridging international financial gaps. Cape Town, South Africa, 18th September 2023: Ennova Holdings, a forward-thinking organization committed to addressing financial inequality in

ESG1 Partners with GMEX ZERO13 on Trading Tokenized Carbon Credits from Emissions Removals

Cross-chain interoperable ESG asset trading and settlement enabled by ZERO13 as a fully integrated market distribution partner for ESG1’s highly verified, IoT-linked industrial carbon credit tokens. London and Calgary, 14 September 2023: ZERO13, a GMEX Group initiative providing a digital climate fintech aggregation ecosystem, and ESG1, a subsidiary of GuildOne providing innovative digital assets and ESG solutions built on R3’s Corda, have announced a landmark collaboration that will create an automated digital pipeline for North American industrial carbon offsets to reach high-demand markets in Europe and the Middle East. ESG1’s

American Picture House Corporate Update

New York, NY, Raleigh, NC, and Los Angeles, CA.  September 6, 2023 – American Picture House Corporation (OTC: APHP), an entertainment company with a focus on producing feature films, limited series, and entertainment enhancing technologies, today provided a corporate update for shareholders. Industry Strikes American Picture House supports the ideals behind the two current industry strikes -- brought by the Writers Guild of America (“WGA”) and the Screen Actors Guild (“SAG”) -- and joins the many reasonable voices urging for a fair and timely resolution. Update on Feature Films -

Starbox Group Holdings Ltd. Announces First Half of Fiscal Year 2023 Financial Results

Revenue and Net Profit Increased with Technology Driven Services Revenue Accounted for Approximately 43.8% of its Revenue KUALA LUMPUR, Malaysia, August 29, 2023 / Plato / Amplifi. Starbox Group Holdings Ltd. (Nasdaq: STBX) ("Starbox" or "the Company”), a service provider of cash rebates, digital advertising, and payment solutions with a goal of becoming a comprehensive AI solutions provider within Southeast Asia, today announced its unaudited financial results for the six months ended March 31, 2023. Mr. Lee Choon Wooi, Chairman and Chief Executive Officer of Starbox, commented, “We are excited

Gain Therapeutics Achieves Remarkable Breakthrough in Parkinson’s Disease Research

Gain Therapeutics, Inc. (Nasdaq: GANX), a pioneering biotechnology company specializing in innovative allosteric small molecule therapies, has made significant strides in the fight against Parkinson's disease (PD). The Company's lead drug candidate, GT-02287, has demonstrated extraordinary potential in mitigating the effects of Parkinson's disease across two distinct preclinical models of the ailment. These findings suggest that GT-02287 has the capacity to alleviate Parkinson's disease pathology and enhance motor function. A notable highlight is the substantial reduction of plasma Neurofilament Light Chain (NfL) levels, an emerging biomarker for neurodegeneration. This advancement

Swiss WEB3FEST 2023: The Convergence of Web3 Innovation and Collaboration

The Global Web3 Ecosystem is set to unite under the banner of "Switzerland United", an 11-day extravaganza, from September 7th-17th 2023, that combines the forces of the NFT Fest Lugano, NFT Lakeside Unconference and the Swiss WEB3FEST. Key Highlights The Swiss WEB3FEST will be the center of Web3 innovation and collaboration, with over 150 Preeminent speakers, 50+ exhibitors and 80+ captivating topics and side events The Swiss WEB3FEST is the Ecosystem Festival of Crypto Valley and Crypto Oasis and is Co-Hosted by Dfinity aka The Internet Computer The Conference is

Why Press Releases are Still an Effective Way to Market Your Business

Even in the Age of Social Media, Press Releases are still an important tool for businesses of all sizes to grow their brand awareness, improve media relations, and to build consumer confidence, and should continued to be used to announce new products or services, promote events, or share other newsworthy information about the company. Key benefits of using press releases to grow your business: Increase brand awareness: Press releases help you reach outside your Social Media subscriber base to a wider audience and introduce your brand to new potential customers.

Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimer’s Disease.

Highlights Coya reports new data illustrating that administration of COYA 301 (low dose Interleukin-2 (IL-2)) in an open- label study in 8 patients with mild to moderate AD (COYA 301 Trial) resulted in a statistically significant reduction in the expression of three well characterized proinflammatory cytokines -- Tumor Necrosis Factor alpha (TNF-α), Interleukin 6 (IL-6), and Interleukin 1- Beta (IL-1β) -- which correlated with lack of cognitive decline of the patients over the course of the study. TNF-α is one of the main inflammatory cytokines involved in initiating and propagating

Press Release: TP ICAP announces first live trade through Fusion Digital Assets with GMEX trading and post-trade technology

Fusion Digital Assets – TP ICAP’s wholesale marketplace for spot cryptoassets – is now live and has successfully completed its first XBTUSD pairs trade with the associated settlement processed by Fidelity Digital Assets℠ London, New York, 24 May 2023: GMEX Technologies (“GMEX”), a subsidiary of GMEX Group, a leader in digital business and technology solutions for capital markets players, exchanges and post-trade market infrastructure, today announced that TP ICAP, the world’s largest interdealer broker, has gone live with its Fusion Digital Assets wholesale cryptoasset exchange, powered by GMEX trading and post trade technology.